James L. Gulley

27.7k citations
568 papers · 18.4k indexed · 6 hit papers · h-index 71
Topics
Cancer Immunotherapy and Biomarkers (261 papers)Immunotherapy and Immune Responses (220 papers)Prostate Cancer Treatment and Research (199 papers)

In The Last Decade

James L. Gulley

553 papers receiving 18.0k citations

Hit Papers

Overall Survival Analysis of a Phase II Randomized Contro...201020262015202020102017201720182019200400600

Peers

James L. Gulley
Comparison fields: 5 of 152
  • Oncology 11.7k
  • Immunology 8.3k
  • Pulmonary and Respiratory Medicine 5.7k
  • Molecular Biology 4.2k
  • Radiology, Nuclear Medicine and Imaging 1.9k
Replace Aurélien Marabelle with:
Aurélien Marabelle France
Andreas D. Hartkopf Germany
Anne Berger France
Ulrich Keilholz Germany
Andreas Engert Germany
Dirk Jäger Germany
Janis M. Taube United States
Paolo A. Ascierto Italy
Barbara Burtness United States
Chuong D. Hoang United States
James L. Gulley relative to Aurélien Marabelle France Aurélien Marabelle's profile →
Citations per field
00.5×3.1×
Aurélien Marabelle · 1×
Citations per year

Countries citing papers authored by James L. Gulley

Since Specialization
Citations

This map shows the geographic impact of James L. Gulley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James L. Gulley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James L. Gulley more than expected).

Fields of papers citing papers by James L. Gulley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James L. Gulley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James L. Gulley. The network helps show where James L. Gulley may publish in the future.

Co-authorship network of co-authors of James L. Gulley

This figure shows the co-authorship network connecting the top 25 collaborators of James L. Gulley. A scholar is included among the top collaborators of James L. Gulley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James L. Gulley. James L. Gulley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 6
3 183
4 45
5 49
6 116
7
Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumorsbreakdown →
327
8 51
9 3
10 26
11 360
12 104
13 36
14 101
15 101
16 45
17 201
18 176
19 119
20 142

About James L. Gulley

James L. Gulley is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 568 papers that have together received 18.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (261 papers), Immunotherapy and Immune Responses (220 papers) and Prostate Cancer Treatment and Research (199 papers). The work is most often cited by research in Oncology (11.7k citations), Immunology (8.3k citations) and Pulmonary and Respiratory Medicine (5.7k citations). James L. Gulley has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Jeffrey Schlom, Ravi A. Madan, Philip M. Arlen, William L. Dahut, Seth M. Steinberg, Christopher R. Heery, Caroline Jochéms, Kwong Y. Tsang, James W. Hodge and Renee N. Donahue. Their work appears in journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026